Price target
101.330.000.00%
The 15 analysts offering 1 year price forecasts for ITCI have a max estimate of — and a min estimate of —.
Analyst rating
Based on 17 analysts giving stock ratings to ITCI in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
ITCI EPS for the last quarter is −0.25 USD despite the estimation of −0.18 USD. In the next quarter EPS is expected to reach −0.06 USD. Track more of Intra-Cellular Therapies Inc. financials and stay on top of what is up with the company.
In the next quarter Intra-Cellular Therapies Inc. revenue is expected to reach 192.67 M USD. Check out Intra-Cellular Therapies Inc. revenue and earnings and make informed decisions.
According to analysts, ITCI price target is 101.33 USD with a max estimate of 135.00 USD and a min estimate of 79.00 USD. Check if this forecast comes true in a year, meanwhile watch Intra-Cellular Therapies Inc. stock price chart and keep track of the current situation with ITCI news and stock market news.
We've gathered opinions of 17 analysts rating ITCI stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.